DGBI
5
1
2
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 5 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Personalised Multidisciplinary Treatment in Moderate to Severe IBS
Evaluation of an Online ACT and Compassion-based Intervention for Disorders of Gut-Brain Interaction
Feasibility and Acceptability of an Online ACT Intervention for Disorders of Gut-Brain Interaction - Beta Trial
Feasibility and Acceptability of an Online ACT Intervention for Disorders of Gut-Brain Interaction
Assessment and Educational Intervention to Reduce Ultra-processed Food Consumption in Pediatric Patients With IBD